NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 43 filers reported holding NEUROPACE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,039,494 | +116.7% | 4,012,281 | 0.0% | 0.83% | +154.3% |
| Q2 2023 | $18,015,142 | -3.2% | 4,012,281 | 0.0% | 0.33% | -10.7% |
| Q1 2023 | $18,616,984 | +211.4% | 4,012,281 | 0.0% | 0.36% | +220.2% |
| Q4 2022 | $5,978,299 | -60.3% | 4,012,281 | 0.0% | 0.11% | -59.1% |
| Q3 2022 | $15,046,000 | -24.2% | 4,012,281 | 0.0% | 0.28% | -22.5% |
| Q2 2022 | $19,861,000 | -39.7% | 4,012,281 | 0.0% | 0.36% | -32.6% |
| Q1 2022 | $32,941,000 | -18.6% | 4,012,281 | 0.0% | 0.53% | +2.7% |
| Q4 2021 | $40,444,000 | -36.4% | 4,012,281 | 0.0% | 0.52% | -25.6% |
| Q3 2021 | $63,595,000 | -33.4% | 4,012,281 | 0.0% | 0.70% | -27.6% |
| Q2 2021 | $95,452,000 | – | 4,012,281 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KCK LTD. | 5,621,111 | $27,824,000 | 39.09% |
| Revelation Capital Management, LLC | 248,127 | $1,228,000 | 17.38% |
| Soleus Capital Management, L.P. | 2,334,003 | $11,553,000 | 1.80% |
| Orbimed Advisors | 4,012,281 | $19,861,000 | 0.36% |
| Opaleye Management Inc. | 90,100 | $446,000 | 0.20% |
| Nantahala Capital Management | 478,438 | $2,368,000 | 0.12% |
| Bellevue Group AG | 507,930 | $2,514,000 | 0.04% |
| Ergoteles LLC | 34,800 | $172,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 26,148 | $129,000 | 0.00% |
| Point72 Asset Management, L.P. | 149,199 | $739,000 | 0.00% |